You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Therapy Areas: Cardiovascular
Eli Lilly launches Foundayo weight‑loss pill in the US
Login
Username:

Password:


Related Headlines

HeartBeam and Mount Sinai partner to advance AI-enabled cardiac monitoring

Medicomp Systems client IJN in Malaysia granted Stage 7 validation from HIMSS EMRAM

Precision BioSciences receives FDA Fast Track designation for PBGENE-DMD

GAIA and Daiichi Sankyo Europe partner on digital therapeutic for cardiovascular care

Esperion to acquire Corstasis, expanding cardiovascular portfolio

Circio reports up to 50-fold gene expression gain in eye for circVec-AAV platform

Celyad Oncology sells C-Cathez catheter to CellProthera

Realheart secures European patent for artificial heart technology

Cumberland Pharmaceuticals secures FDA Fast Track status for DMD heart‑disease therapy ifetroban

Boehringer Ingelheim's VETMEDIN gains US FDA approval to delay congestive heart failure onset in dogs

Myqorzo and Redemplo receive regulatory approval in China

Cereno Scientific publishes first peer-reviewed data on CS014, highlighting antithrombotic efficacy without bleeding risk

Kestra partners with Biobeat to add cuffless blood pressure monitoring to wearable defibrillator

Organon signs commercialisation agreement for Nilemdo across six European markets

Antin to acquire clinical trial equipment provider Emsere

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026